SEC Filing Summary: India Globalization Capital, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K Current Report was filed by India Globalization Capital, Inc. on March 11, 2011. The report discloses a corporate governance event regarding the Board of Directors. Note: The input metadata references "IGC Pharma, Inc.," but the filing text explicitly identifies the registrant as "India Globalization Capital, Inc."
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a disclosure of personnel changes and does not contain financial statements or performance data.
Material Changes
The material change reported is the resignation of Mr. Suhail Nathani from the Board of Directors. His resignation became effective on March 15, 2011. Mr. Nathani was one of the company's two current Class A directors, with a term scheduled to end at the 2011 annual meeting of shareholders.
Management Commentary and Risks
Management stated that Mr. Nathani's resignation was due to his increased role in matters involving governments and regulatory bodies in India and a desire to devote additional time to other business endeavors. The filing explicitly confirms that the resignation was not the result of any disagreements with the Company regarding its operations, policies, or practices. No specific risks, contingencies, or unusual items were disclosed in this report.
Key Facts for Investor Verification
- Mr. Suhail Nathani resigned as a Class A Director effective March 15, 2011.
- The resignation was voluntary and unrelated to any disputes with the company.
- The company had only two Class A directors at the time of the filing.
- No financial data or operational metrics are included in this specific filing.